Abstract
Objective The study was conducted to determine the prevalence of red blood cell alloantibodies for transfused patients in the East Taiwanese population. Materials and Methods We analyzed the clinical and transfusion records of 15,794 individuals who received transfusions in Hualien Tzu Chi Hospital from 2004 to 2006. Blood samples were subjected to standard blood bank procedures for screening for antibodies. Results Of the 15,794 transfused patients, 538 patients (3.39%) were found to have alloantibodies. Among these 538 patients, 333 patients were found to carry alloantibodies at the initial transfusion (2.0%) and 205 (1.3%) patients developed alloantibodies during the transfusion period. Conclusion Our data demonstrate that anti-Mi a was the most frequently detected alloantibody in the Eastern Taiwanese population, with an incidence (1.5%) that was higher than reported in other Taiwanese populations.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
